<PAGE>
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 8-K
Current Report Pursuant to Section 13 or 15(d) of
The Securities Act of 1934
Date of Report (Date of earliest event reported): March 16, 1999
NEUROMEDICAL SYSTEMS, INC.
(Exact name of registrant as specified in its charter)
<TABLE>
<S> <C> <C>
Delaware 0-26984 13-3526980
(State or other (Commission File No.) (I.R.S. Employer
jurisdiction Identification No.)
of incorporation)
10 Mountain View Road
Suite C-100
Upper Saddle River, NJ 07458-1933
(Address of principal executive offices) (Zip Code)
</TABLE>
Registrant's telephone number, including area code: (201) 934-0660
<PAGE>
ITEM 5.
- -------
NSI NETHERLANDS, B.V. ENTERS MORATORIUM PERIOD AND CEASES GERMAN OPERATIONS
- ---------------------------------------------------------------------------
On March 16, 1999, Neuromedical Systems, Inc. (the "Company"), announced
that a Netherlands court has granted NSI Netherlands, B.V.'s application for a
moratorium, and has appointed an administrator. NSI Netherlands B.V., a
subsidiary of the Company, serves as the Company's base of European operations.
During the moratorium, NSI Netherlands, B.V. will evaluate its options,
including whether to continue operations or to commence insolvency proceedings.
In connection with this reassessment, the Company has also decided to cease its
operations in Germany.
NSI SECURITIES DELISTED FROM NASDAQ; ELIGIBLE TO BE
- ----------------------------------------------------
TRADED ON OTC BULLETIN BOARD
- ----------------------------
On March 17, 1999 the Company announced that it had received
notification from NASDAQ that the Company's securities have been delisted from
the NASDAQ National Market System. The Company's securities are immediately
eligible to be traded on the OTC Bulletin Board.
###
<PAGE>
Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized in Upper Saddle River, New Jersey on this
17th day of March, 1999.
NEUROMEDICAL SYSTEMS, INC.
By: /s/ Mark L. Smith
-----------------------------------------
Mark L. Smith
Vice President, Finance and
Administration and Chief Financial Officer
